1.

Record Nr.

UNINA9910418354703321

Autore

Jamrozik Euzebiusz

Titolo

Human challenge studies in endemic settings : ethical and regulatory issues / / Euzebiusz Jamrozik, Michael J. Selgelid

Pubbl/distr/stampa

Springer Nature, 2021

Cham, Switzerland : , : Springer Nature Switzerland AG : , : Imprint : SpringerOpen, , [2021]

©2021

ISBN

3-030-41480-9

Descrizione fisica

1 online resource (xvii, 134 pages) : illustrations; PDF, digital file(s)

Collana

SpringerBriefs in Ethics, , 2211-8101

Disciplina

171.7

Soggetti

Bioethics

Infectious diseases

Vaccines

Economic development

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

1. Introduction -- 2. Methods -- 3. History of human challenge studies -- 4. ethical issues -- 5. Community engagement, ethics review, and regulation -- 6. Case studies -- 7. Conclusions -- Acknowledgements. .

Sommario/riassunto

This open access book provides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs). Human challenge studies (HCS) involve the intentional infection of research participants, and this type of research is rapidly increasing in frequency worldwide. HCS are widely considered to be an especially promising approach to vaccine development, including for pathogens endemic to LMICs. However, challenge studies are sometimes controversial and raise complex ethical issues, some of which are especially salient in endemic and/or LMIC settings. Informed by qualitative interviews with experts in infectious diseases and bioethics, this book highlights areas of ethical consensus and controversy concerning this kind of research.



As the first volume to focus on ethical issues associated with human challenge studies, it sets the agenda for further work in this important area of global health research; contributes to current debates in research ethics; and aims to inform regulatory policy and research practice. Insofar as it focuses on HCS in (endemic) settings where diseases are present and/or widespread, much of the analysis provided here is directly relevant to HCS involving pandemic diseases including COVID19.